Menu Close
Professor of Health Economics, University of Wollongong

Senior Professor Eckermann is an internationally renown health economist known for his methodological tools that enable governments to compare medical system data and outcomes in a like for like manner.

Experience

  • 2010–present
    Professor of Health Economics, University of Wollongong
  • 2008–2010
    Professor of Health Economics, Flinders University
  • 2005–2008
    A/Professor of Health Economics, Flinders University
  • 1999–2005
    Senior Health Economist, NHMRC Clinical Trial Centre

Education

  • 2005 
    UNSW, PhD Health Economics
  • 1998 
    University of Adelaide, BMSc
  • 1995 
    Tromso University , Grad Dip H.Ec
  • 1991 
    University of Adelaide, B.Ec (Hons.)
  • 1990 
    University of Adelaide , B.Ec

Publications

  • 2014
    Avoiding a health system hernia and the associated outcomes and costs, ANZJPH
  • 2014
    Can the real opportunity cost stand up: displaced services the straw man outside the room., PharmacoEconomics
  • 2014
    Evaluating return on investment in a school based health promotion and prevention program: the investment multiplier for the Stephanie Alexander Kitchen Garden National Program. , Social Science and Medicine
  • 2013
    Including quality attributes in efficiency measures consistent with net benefit: creating incentives for evidence based medicine in practice, Social Science and Medicine
  • 2013
    Optimal global VOI trials: better aligning manufacturer and decision maker interest and enabling feasible risk sharing, PharmacoEconomics
  • 2012
    Expected value of information and pricing new health care interventions, PharmacoEconomics
  • 2011
    Consistently estimating absolute risk difference when translating evidence to jurisdictions of interest., PharmacoEconomics
  • 2011
    Accounting for between-study variation in incremental net benefit in value of information methodology, Health Economics
  • 2011
    Presenting evidence and summary measures to best inform societal decisions when comparing multiple strategies, PharmacoEconomics
  • 2010
    The value of Value of Information: best informing research design and prioritization using current methods, PharmacoEconomics
  • 2010
    Optimal clinical trial design using value of information with imperfect implementation, Health Economics
  • 2009
    Indirect comparison: relative risk fallacies and odds solution, Journal of Clinical Epidemiology
  • 2009
    Globally optimal trial design for local decision making, Health Economics
  • 2008
    Time and Expected Value of Sample Information Wait for No Patient, Value in health
  • 2008
    Health Technology Assessment in the Cost-Disutility Plane, Medical Decision Making
  • 2007
    Expected Value of Information and Decision Making in HTA, Health Economics